Clinical Trial Update: A Pharmacodynamic/Pharmacokinetic Study of Aleglitazar in Patients With Type 2 Diabetes Mellitus on Treatment With Lisinopril [Phase 1]

View source ↗

Summary

This Phase 1 trial reports pharmacodynamic and pharmacokinetic data for aleglitazar in patients with type 2 diabetes mellitus who are on lisinopril; the study h…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Aleglitazar (Aleglitazar)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Diabetes Mellitus Type 2 | Phase 1 | Status: COMPLETED